<DOC>
	<DOC>NCT00695643</DOC>
	<brief_summary>The purpose of the study is to determine whether mesalazine granules compared to placebo is effective in prevention of recurrence of disease.</brief_summary>
	<brief_title>Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis</brief_title>
	<detailed_description>The purpose of the study is to demonstrate the superiority of mesalazine granules compared to placebo in terms of the primary efficacy variable proportion of recurrence-free patients within 48 weeks.</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Diverticulitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Diagnosis of leftsided uncomplicated diverticular disease confirmed by ultrasonography or computed tomography Presence of at least one diverticulum of the left colon Most recent attack of leftsided uncomplicated diverticulitis responding to antibiotics and/or dietary modification within the last 6 months Creactive protein (CRP) &gt; upper limit of normal (ULN) at the start of the most recent attack Complicated diverticular disease Rightsided diverticulitis Previous colonic surgery Presence of symptomatic organic disease of the gastrointestinal tract Active colorectal cancer or a history of colorectal cancer Hemorrhagic diathesis Active peptic ulcer disease, local intestinal infection Asthma if careful medical monitoring is not ensured Abnormal hepatic function or liver cirrhosis Abnormal renal function</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>